The significance of carrying MEFV variants in symptomatic and asymptomatic individuals
Clinical Genetics · 2024-09 · 106 (3) · 217-223
DOI: 10.1111/cge.14566 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Genetics, online erschienen am 31.05.2024. Verfasst von Eldad Ben-Chetrit und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: Familial Mediterranean Fever, Pyrin, Mutation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Familial Mediterranean fever (FMF) is an autoinflammatory disease characterized by recurrent attacks of fever, serositis (peritonitis, pleuritis, or synovitis), and erysipelas‐like erythema. Genetic variants in the MEFV gene are associated with this disease. Familial Mediterranean fever is considered an autosomal recessive disease. However, in Middle Eastern countries, a third of the patients expressing FMF manifestations, carry a single mutation only. Moreover, some cases of pure dominant inheritance linked to specific single MEFV variants have also been described. This complex inheritance of MEFV ‐associated inflammatory diseases poses a serious challenge when interpreting the results of genetic testing in patients having recurrent fever syndromes. In addition, in certain situations, asymptomatic individuals may be incidentally found to carry MEFV variants. These cases pose the question of their exact diagnosis and whether they should be treated. Previous studies have focused on genetic results interpretations among symptomatic patients. In the current article, we would like to elaborate on the genetic interpretation in cases of symptomatic individuals suspected to have FMF and on asymptomatic individuals carrying MEFV variants. We aim to assist physicians unfamiliar with FMF to cope with genetic results interpretation when facing symptomatic and asymptomatic individuals carrying MEFV variants and suggest a management plan accordingly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
- CEREMAIA, Department of Genetics, CHU of Montpellier, INSERM, University of Montpellier, Montpellier, France.
ORCID-Profile: Eldad Ben-Chetrit, Isabelle Touitou
Zitieren
APA
Ben-Chetrit, E., & Touitou, I. (2024). The significance of carrying MEFV variants in symptomatic and asymptomatic individuals. Clinical Genetics, 106(3), 217-223. https://doi.org/10.1111/cge.14566
Vancouver
Ben-Chetrit E, Touitou I. The significance of carrying MEFV variants in symptomatic and asymptomatic individuals. Clinical Genetics. 2024;106(3):217-223. doi:10.1111/cge.14566
BibTeX
@article{BenChetrit2024,
author = {Ben-Chetrit, Eldad and Touitou, Isabelle},
title = {The significance of carrying MEFV variants in symptomatic and asymptomatic individuals},
journal = {Clinical Genetics},
year = {2024},
volume = {106},
number = {3},
pages = {217--223},
doi = {10.1111/cge.14566}
}
EUVIMED